Rhumbline Advisers Lowers Stake in Cabot Corporation $CBT

Rhumbline Advisers lowered its position in Cabot Corporation (NYSE:CBTFree Report) by 6.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 181,281 shares of the specialty chemicals company’s stock after selling 12,458 shares during the quarter. Rhumbline Advisers owned approximately 0.34% of Cabot worth $13,786,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the business. Smartleaf Asset Management LLC raised its position in shares of Cabot by 598.0% in the 3rd quarter. Smartleaf Asset Management LLC now owns 349 shares of the specialty chemicals company’s stock worth $27,000 after acquiring an additional 299 shares in the last quarter. Elevation Point Wealth Partners LLC purchased a new position in Cabot in the second quarter valued at about $28,000. Parkside Financial Bank & Trust grew its stake in Cabot by 95.5% in the second quarter. Parkside Financial Bank & Trust now owns 387 shares of the specialty chemicals company’s stock valued at $29,000 after purchasing an additional 189 shares during the last quarter. Hantz Financial Services Inc. raised its holdings in Cabot by 227.5% in the third quarter. Hantz Financial Services Inc. now owns 429 shares of the specialty chemicals company’s stock worth $33,000 after purchasing an additional 298 shares in the last quarter. Finally, Geneos Wealth Management Inc. lifted its position in shares of Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after buying an additional 364 shares during the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently commented on CBT. Mizuho set a $75.00 price objective on shares of Cabot and gave the stock a “neutral” rating in a research note on Wednesday, February 4th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $85.00 price target on shares of Cabot in a report on Wednesday, February 4th. UBS Group increased their price objective on Cabot from $74.00 to $81.00 and gave the company a “neutral” rating in a report on Thursday, February 5th. JPMorgan Chase & Co. lowered their price target on Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a report on Friday, November 28th. Finally, Zacks Research upgraded shares of Cabot from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 27th. One research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $73.75.

Get Our Latest Analysis on CBT

Cabot Trading Down 0.5%

Shares of Cabot stock opened at $74.98 on Friday. The firm has a 50-day simple moving average of $71.13 and a two-hundred day simple moving average of $71.74. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.09 and a current ratio of 1.67. Cabot Corporation has a fifty-two week low of $58.33 and a fifty-two week high of $89.15. The company has a market cap of $3.92 billion, a P/E ratio of 13.13, a price-to-earnings-growth ratio of 4.01 and a beta of 0.88.

Cabot (NYSE:CBTGet Free Report) last announced its quarterly earnings results on Tuesday, February 3rd. The specialty chemicals company reported $1.53 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.13. Cabot had a return on equity of 22.82% and a net margin of 8.62%.The firm had revenue of $849.00 million during the quarter, compared to analyst estimates of $889.11 million. During the same quarter in the previous year, the business earned $1.76 EPS. Cabot’s revenue for the quarter was down 11.1% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. As a group, equities analysts predict that Cabot Corporation will post 7.57 earnings per share for the current fiscal year.

Cabot Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Shareholders of record on Friday, February 27th will be issued a dividend of $0.45 per share. The ex-dividend date of this dividend is Friday, February 27th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.4%. Cabot’s dividend payout ratio is presently 31.52%.

Cabot Company Profile

(Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Further Reading

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.